Backs FY26 revenue view $600M-$610M, consensus $602.04M.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATRC:
- AtriCure reports Q4 adjusted EPS 6c, consensus (11c)
- ATRC Earnings this Week: How Will it Perform?
- AtriCure: Sustained Growth and Market Leadership Expected Despite Emerging Competition
- AtriCure: Solid Growth Drivers but Rising Competitive Threat from Edwards Justifies Neutral Stance
- AtriCure downgraded to Neutral from Overweight at JPMorgan